ABBV vs STRO
AbbVie Inc (ABBV) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ABBV and STRO stock pages for the full models.
Not investment advice.